Press Releases

SEATTLE, Dec. 26, 2019 /PRNewswire/ -- QuoteWizard®, a LendingTree company, and one of the nation's leading online insurance marketplaces, released a

ATLANTA, Dec. 26, 2019 /PRNewswire/ -- The American Cancer Society (ACS) is widening its opportunities for participants in 2020 through the DetermiNation Endu

GARDENA, Calif., Dec. 26, 2019 /PRNewswire/ -- Every year we hear tragic incidents involving pets and the cold weather. That's why this year, Innovet Pet is helping dog owners learn what they can do to keep their little furry ones safe during the winter. In their recent

TAIPEI, Taiwan, Dec. 26, 2019 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-999 for the treatment of Pancreatic Cancer. OBI-999 is a first-in-class antibody drug conjugate targeting Globo H, a glycolipi

SHANGHAI, Dec. 25, 2019 /PRNewswire/ -- To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry--- bioLIVE China 2020, will be held again at Hall W4 in the SNIEC on June 22-24, 2020

PITTSBURGH, Dec. 24, 2019 /PRNewswire/ -- InventHelp® introduces "BLADDERVOID," a medical device designed to provide deep, soothing heat to the muscles and nerves of the male genital area.

TOKYO, Dec. 24, 2019 /PRNewswire/ -- The END ALS Association (Representative: Motoi Ito, Tokyo, Japan) announced the launch of their Merry & Bright - EEG Illumination project. The objective of this project is to enable Masahiro "Hiro" Fujita,

READING, Pa., Dec. 24, 2019 /PRNewswire/ -- PharmaForce International recently released two separate reports that focus on the benchmarking of biosimilar sales and marketing organizations in France, Germany, Italy, Spain, and the

NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 24, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application

BEIJING, Dec. 24, 2019 /PRNewswire/ -- The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held in Beijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor.Dr. David Xu, the Chief Business Officer of Viva Biotech, was invit